Terms: = Kidney tumors AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
10 results:
1. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
2. Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant treatment of Renal Cell Carcinoma Post-nephrectomy in the United States.
Lai Y; Bensimon AG; Gao E; Bhattacharya R; Xu R; Chevure J; Imai K; Haas NB
Clin Genitourin Cancer; 2023 Oct; 21(5):612.e1-612.e11. PubMed ID: 37137809
[TBL] [Abstract] [Full Text] [Related]
3. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer treatment.
Wallach JD; Deng Y; McCoy RG; Dhruva SS; Herrin J; Berkowitz A; Polley EC; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Shah ND; Ross JS; Lyon TD
JAMA Netw Open; 2021 Oct; 4(10):e2130587. PubMed ID: 34677594
[TBL] [Abstract] [Full Text] [Related]
4. Cytoreductive Nephrectomy Following Immunotherapy-Base treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.
Dawsey SJ; Campbell SC; Ornstein MC
Curr Oncol; 2021 May; 28(3):1921-1926. PubMed ID: 34065284
[TBL] [Abstract] [Full Text] [Related]
5. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
[TBL] [Abstract] [Full Text] [Related]
6. Oral and injectable Marsdenia tenacissima extract (MTE) as adjuvant therapy to chemotherapy for gastric cancer: a systematic review.
Zhou X; Liu M; Ren Q; Zhu W; Wang Y; Chen H; Chen J
BMC Complement Altern Med; 2019 Dec; 19(1):366. PubMed ID: 31830977
[TBL] [Abstract] [Full Text] [Related]
7. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
8. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
Alistar A; Morris BB; Desnoyer R; Klepin HD; Hosseinzadeh K; Clark C; Cameron A; Leyendecker J; D'Agostino R; Topaloglu U; Boteju LW; Boteju AR; Shorr R; Zachar Z; Bingham PM; Ahmed T; Crane S; Shah R; Migliano JJ; Pardee TS; Miller L; Hawkins G; Jin G; Zhang W; Pasche B
Lancet Oncol; 2017 Jun; 18(6):770-778. PubMed ID: 28495639
[TBL] [Abstract] [Full Text] [Related]
9. Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study.
Schüz J; Schmidt LS; Kogner P; Lähteenmäki PM; Pal N; Stokland T; Schmiegelow K
Int J Cancer; 2011 May; 128(9):2166-73. PubMed ID: 20607831
[TBL] [Abstract] [Full Text] [Related]
10. kidney transplantation and tumours.
Forslund T; Kock B; Kuhlbäck B
Ann Clin Res; 1980 Apr; 12(2):55-8. PubMed ID: 7004326
[TBL] [Abstract] [Full Text] [Related]
